Insights that cut through complexity

Hemgenix became the most expensive drug in the history of FDA-approvals back in November of 2022 after the manufacturer, CSL Behring, hung a $3.5 million

This might come as a surprise to some individuals as they dive into the listed ingredients of the newest FDA-approved anti-depressant to hit the market,

The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be

As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many years, the topic has been

Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify the symptoms of osteoarthritis, a

See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum.  People who live with narcolepsy — about one out of every

RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve. Below is an excerpt.  Psoriasis

Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve cells in the spinal cord

An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’ lives significantly. Enhertu is a

Recent months have brought new waves of viral infections across the globe, particularly, monkeypox. Scientists first identified monkeypox in Denmark in the late 1950s in

Jason Peterson and RemedyOne EVP of clinical services Robert Louie have also written about Mounjaro for Pharmaphorum.  Man o’ War, Seabiscuit, Secretariat, Seattle Slew, Trulicity,

Some say things get better with age. Cheese, wine, and whiskey are a few examples that come to mind. Unfortunately, your vision is not one

See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum.  It has now been over six months since